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Collectrin, a homologue of angiotensin converting enzyme 2 (ACE2), is a type I transmembrane protein, and we originally
reported its localization to the cytoplasm and apical membrane of collecting duct cells. Recently, two independent studies of
targeted disruption of collectrin in mice resulted in severe and general defects in renal amino acid uptake. Collectrin has been
reported to be under the transcriptional regulation by HNF-1a, which is exclusively expressed in proximal tubules and localized
at the luminal side of brush border membranes. The deficiency of collectrin was associated with reduction of multiple amino
acid transporters on luminal membranes. In the current study, we describe that collectrin is a target of HNF-1b and heavily
expressed in the primary cilium of renal collecting duct cells. Collectrin is also localized in the vesicles near the peri-basal body
region and binds to c-actin-myosin II-A, SNARE, and polycystin-2-polaris complexes, and all of these are involved in
intracellular and ciliary movement of vesicles and membrane proteins. Treatment of mIMCD3 cells with collectrin siRNA
resulted in defective cilium formation, increased cell proliferation and apoptosis, and disappearance of polycystin-2 in the
primary cilium. Suppression of collectrin mRNA in metanephric culture resulted in the formation of multiple longitudinal cysts
in ureteric bud branches. Taken together, the cystic change and formation of defective cilium with the interference in the
collectrin functions would suggest that it is necessary for recycling of the primary cilia-specific membrane proteins, the
maintenance of the primary cilia and cell polarity of collecting duct cells. The transcriptional hierarchy between HNF-1b and
PKD (polycystic kidney disease) genes expressed in the primary cilia of collecting duct cells has been suggested, and collectrin
is one of such HNF-1b regulated genes.
Citation: Zhang Y, Wada J, Yasuhara A, Iseda I, Eguchi J, et al (2007) The Role for HNF-1b-Targeted Collectrin in Maintenance of Primary Cilia and Cell
Polarity in Collecting Duct Cells. PLoS ONE 2(5): e414. doi:10.1371/journal.pone.0000414
INTRODUCTION
In a previous study, we identified a member of angiotensin con-
verting enzyme (ACE) gene family, collectrin, by its up-regulation
in a mouse model of partial nephrectomy [1], which is a long-
standing model for the progressive renal diseases. Collectrin is
a type I transmembrane protein and we originally reported its
localization to the cytoplasm and apical membrane of collecting
duct cells. It is a homologue of ACE2 and identified in immediate
proximity of the ace2 locus. ACE2 may be a chimeric protein
emerging from the duplication of two genes, having homology
with ACE at the catalytic domain and homology with collectrin in
the membrane proximal domain[2]. Unlike ACE and ACE2,
collectrin lacks N-terminal active dipeptidyl carboxypeptidase
catalytic domain, and thus its biology has not been well-estab-
lished. Recently, two independent studies of targeted disruption of
collectrin in mice resulted in a severe and general defects in renal
amino acid uptake[3,4]. Collectrin is demonstrated at the luminal
side of brush border membranes of proximal tubules and the
deficiency of collectrin is associated with reduction of multiple
amino acid transporters, such as B0AT1, rBAT, B
0,+AT[4],
XT3s1/ST1, XT2, XT3 and EAAC1[3], on luminal membranes.
We and others have described the expression of collectrin in
pancreatic b cells and collectrin is identified as a target of hepato-
cyte nuclear factor-a (HNF-1a)[5,6]. Targeted disruption of HNF-
1a resulted in diabetes and a renal phenotype with Fanconi
syndrome characterized by glucosuria, phosphaturia, calciuria and
aminoaciduria[7]. Localization of HNF-1a in proximal tubules
and similar renal phenotype in collectrin and HNF-1a knockout
mice suggested that the expression of collectrin in proximal tubules
is transcriptionally regulated by HNF-1a. In contrast to HNF-1a,
the renal-specific inactivation of HNF-1b develops polycystic
kidney disease, and renal cyst formation is accompanied with
a drastic defect in the transcriptional activation of several poly-
cystic kidney disease (PKD)-related genes, such as Umod, Pkhd1,
Pkd2 and Tg737/Polaris[8]. Similarly, mutations in HNF-1b gene
are seen in the autosomal dominant disorder MODY5 (maturity-
onset diabetes mellitus of the young, type 5)[9] and MODY5
patients present type 2 diabetes and develop congenital kidney
abnormalities including simple cysts, polycystic kidneys, cystic
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collectrin and HNF-1b in collecting duct cells suggested that
collectrin is also regulated by HNF-1b and play roles in renal cyst
formation or sodium and water handling. Collectrin knockout
mice are lacking in the phenotype of diabetes, hypertension and
renal cystic formation[3,4]; however, it can be speculated that
collectrin play a role in the pathophysiology of pancreatic b cells
and collecting duct cells because many other genes, such as ACE2,
may compensate the action of collectrin in the gene disruption
studies. For instance, overexpression of collectrin in INS1-E cells
and insulin promoter driven collectrin transgenic mice enhanced
glucose-induced insulin exocytosis. Collectrin binds to SNARE
(soluble N-ethylmaleiamide-sensitive factor attachment protein
receptor) complex by interacting with snapin, a SNAP-25
(synaptosomal-associated protein of 25 kDa) binding protein,
and facilitates the SNARE complex formation[10]. Thus, collec-
trin facilitates the insulin excytosis by regulating the SNARE
complex formation. Based on line of evidences, we hypothesized
that collectrin plays a role in vesicle trafficking of various apical
membrane proteins in a polarized manner by which we can easily
explain why the recruitment of multiple amino acid transporters at
apical membranes is disturbed by collectrin deficiency.
Here, we investigated the role of collectrin using collecting duct
cell lines (mIMCD-3 cells), Ksp-cadherin promoter driven domi-
nant-negative HNF1b mutant (DN-HNF1b) [11] and HNF-1b
deletion mutant lacking C-terminal domain (HNF1bDC) transgenic
mice[12]. We have demonstrated that HNF-1b controls the
transcriptional activities of collectrin. Furthermore, collectrin is
preferentially associated with primary cilium and is shown to play
a role in primary cilium formation, cell polarity and maturation
revealed by siRNA experiments. We also demonstrated that the
expression of collectrin on vesicles in peri-basal body region and its
ability to bind to SNARE complex by interacting with snapin and to
form complex with ciliary proteins, such as polycistin-2 and polaris.
Collectrin may mediate specific vesicle transport, upon docking
deliver the integral membrane proteins to ciliary plasmalemma, and
maintain the primary cilia and cell polarity in collecting duct cells.
MATERIALS AND METHODS
Animals
Ksp-cadherin promoter regulated dominant-negative HNF1b
mutant (DN-HNF1b) transgenic mice[11] and HNF-1b deletion
mutant lacking C-terminal domain (HNF1bDC) transgenic
mice[12] were produced by the University of Texas Southwestern
Transgenic Core Facility.
Preparation of stable mIMCD3 cell lines
overexpressing collectrin
The nucleotide sequence encoding myc epitope, GAACAAAAACT-
CATCTCAGAAGAGGATCTG, was introduced into human
collectrin cDNA in frame distal to the signal sequence by PCR
and then subcloned into pcDNA3.1 to generate expression vector
pcDNA3.1-myc-collectrin. mIMCD3 cells (ATCC) were transfected
with pcDNA3.1-myc-collectrin plasmid using Lipofectamine 2000
reagent (Invitrogen). Stable transformants were selected by the
treatment of Geneticin (300 mg/ml, Sigma).
Cloning of 59 flanking promoter region of rat,
mouse, and human collectrin and transcriptional
elements scanning
The 59 flanking promoter regions of rat, mouse, and human
collectrin genes were cloned into pT7 blue vector (Invitrogen)
using Genome Walker Kit (Clontech) as described previously[13].
Following which the DNA sequences for transcriptional elements
were identified by using TRANSFAC database of weighted
matrices of transcription factor binding sites.
Generation of collectrin antibodies
Polyclonal antibodies were raised in rabbits against the mixture of
synthetic peptides derived from mouse collectrin amino acid
sequence, AFSMRKVPNREATEISH (55-71) and AAEVQSA-
IRKNRNRINS (98-114) using custom polyclonal antibody pro-
duction service (Asahi Techno Glass Corp., Tokyo, Japan). The
specific binding to both peptides and the titers were confirmed by
ELISA (enzyme-linked immunosorbent assay) (Asahi Techno
Glass Corp).
Electrophoretic mobility shift assay (EMSA)
Plasmids encoding the full length of human HNF-1a and HNF1b
were prepared by PCR from human kidney cDNA and cloned
into pcDNA3.1(+) vector (Invitrogen). Nuclear proteins were
extracted using Nuclear Extract Kit (Active Motif) from mIMCD3
cells with or without pcDNA3.1/HNF-1a transfection. EMSAs
were performed with Dig Gel Shift Kit 2nd generation (Roche).
Nuclear protein (2 mg) was incubated with digoxygenin-labelled
oligonucleotide containing HNF-1 binding site of the human
collectrin gene (59-GATGGGTGTTAATCATTAAACCTTT-
39). The DNA-protein complexes were loaded on 5% poly-
acrylamide non0denaturing gels. The monoclonal HNF-1a and
HNF-1b antibody (Transduction Laboratories) was used for
supershift assays.
Transient transfection and luciferase-reporter assay
Promotor region segments of human collectrin containing putative
HNF-1 binding site were generated by PCR and cloned into pGL3
basic reporter vector (Promega)[13]. mIMCD3 cells were co-
transfected with 0.5–1.0 mg of pcDNA3.1/HNF-1a and/or
pcDNA3.1/HNF-1b vectors, 0.5 mg of pGL3-collectrin reporter
and 10 ng of pBIND vector using Lipofectamine 2000 reagent.
48 hours following transfection, the cells were lysed in 500 ml
passive lysis buffer (Promega), firefly and renilla luciferase activities
were measured using the Dual-Luciferase Reporter Assay System
(Promega). The luciferase activity was expressed as the ratio of
firefly and renilla luciferase activity.
Western blotting
Subcellular fractions of SD rat and CD-1 mouse kidneys were
prepared by differential centrifugation as described[14]. Briefly, an
initial spin was carried out at 800 g to remove nuclei and
incompletely homogenized cellular debris. The supernatant was
spun at 17,000 g for 20 min to pellet the plasma membranes (PM);
the 17,000 g supernatant was subjected to a high-speed centrifu-
gation (200,000 g) for 60 min in a Beckman 70Ti rotor to sediment
the intracellular vesicle membranes (VM). The protein lysates of
mIMCD3 cells, whole kidney and its subcellular fraction were
subjected to SDS-PAGE and transferred to Nylon membranes.
The membranes were treated with specific antibodies (1:1000
dilution), such as mouse anti-HNF-1a and HNF-1b (Transduction
Laboratories), polyclonal anti-SNARE associated protein (snapin)
(Synaptic Systems, Go ¨ttingen, Germany), rabbit anti-rat aqua-
porin-2, goat anti-polycystin-2, rabbit anti-epidermal growth
factor receptor (EGFR)(Santa Cruz Biotechnology, Santa Cruz,
CA), and rabbit anti-collectrin, overnight at 4uC and followed by
the treatment with secondary antibodies conjugated with horse-
radish peroxidase (1:20000 dilution)[15].
HNF-1b-Targeted Collectrin
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The mouse medullary total protein was extracted and used for N-
deglycosylation analysis. N-Glycosidase F Deglycosylation Kit was
used following vendor’s instructions (Roche). About 500 mg
protein was incubated with 10 U of O-Glycosidase (Roche) for
3 h at 37uC. The reaction mixtures were then subjected to
Western blot analyses.
Yeast two-hybrid screening and tandem affinity tag
(TAP) purification
Collectrin cDNA encoding intracellular domain was subcloned to
pGBKT7 bait vector and mouse kidney library was constructed
using pGADT7-Rec vector. Yeast two-hybrid screening was
performed according to the manufacturer’s protocol (BD Bios-
ciences Clontech). The collectrin cDNA containing full coding
region without N-terminal signal sequence was cloned into
pNTAP (Stratagene) and transiently transfected into mIMCD3
cells. Final purified proteins were analyzed with SDS-PAGE and
Coomassie blue staining. The major bands were isolated and
subjected to MALDI-TOF MS (mass spectrometry).
Immunoprecipitation studies of mIMCD-3 cell lines
mIMCD3 cells were lysed in RIPA buffer (20 mM Tris-HCl,
pH 7.4, 100 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, and 1%
Triton X-100) with protease inhibitor cocktail (Roche Diagnostics
Co., Basel, Switzerland). The lysates were centrifuged at 12,000 g
for 30 minutes at 4uC and the supernatants were incubated with
the preimmune sera and protein A-Sepharose CL-4B (Amersham
Biosciences, GE Healthcare, Uppsala, Sweden). Immunoprecipi-
tations were performed by adding 10 ml of specific sera and 80 ml
of protein-A Sepharose CL-4B to 0.5 ml of supernatants further
incubated overnight at 4uC on a rocking platform. The
immunoprecipitated complexes were dissolved in a gel-loading
buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol,
100 mM DTT, and 0.1% bromophenol blue), subjected to SDS-
PAGE under the reducing condition, and electroblotted onto
Hybond P PVDF membranes (Amersham Biosciences, Piscat-
away, NJ). They were immunoblotted with specific antibodies
(1:100 to 1:1000) overnight at 4uC and followed with the second-
ary antibodies conjugated with horseradish peroxidase (1:20000).
Finally, the filters were immersed in ECL Plus Western Blotting
Detection Reagents (Amersham), and then exposed to Hyperfilm
ECL (Amersham). Rabbit anti-rat snapin (Synaptic Systems), goat
anti-human SNAP-23 (synaptosomal-associated protein 23 kDa),
goat anti-human syntaxin-4, goat anti-polycystin-2 (Santa Cruz),
rabbit anti-polaris, rabbit c-actin (Novus Biologicals, Littleton,
CO), rabbit anti-tropomyosin (CHEMICON, Temecula, CA)
antibodies were used for immunoprecipitation and Western blot
analyses. Normal rabbit and goat IgGs were used for negative
controls of immunoprecipitation.
Experiments with collectrin specific siRNA
siTrio targeting mouse collectrin (NM_020626;59-CCATAAGA-
ATGAACAGAATT-39,5 9-GCAGAAGACAAGTGTGAAATT-
39,5 9-CAACAATAGACCACTGAAATT-39)(Collectrin siRNA)
and siTrio negative control cocktail containing double stranded
RNAs (59-ATCCGCGCGATAGTACGTATT-39,5 9-TTACGC-
GTAGCGTAATACGTT-39 and 59-TATTCGCGCGTATAG-
CGGTTT-39)(CON siRNA) were purchased from DHARMA-
CON and transfection of mIMCD3 cells was carried out with
Lipofectamine 2000 reagent. Following experiments were per-
formed 24 hours after the transfection. Cells in chamber slides
were stained with mouse anti-PCNA monoclonal antibody (BD
Transduction Lab) using R.T.U Vectastain Universal Quick kit
(Vector Laboratories, Burlingame, CA, U.S.A.), apoptosis was
evaluated with the DeadEndTM Colorimetric TUNEL System
(Promega), and cell viability was assessed by MTT based
colorimetric assay for the cell proliferation and viability (Roche).
Western blot analyses and immunofluorescence were carried out
using rabbit anti-EGFR (epidermal growth factor receptor)
polyclonal antibody (1:2000 dilution, Santa Cruz). For immuno-
fluorescnce, cells grown in chamber slides were fixed in 4%
paraformaldehyde for 30 minutes at 4uC, and then permeabilized
with 0.1% Triton X-100 in PBS for 3 min if necessary. After
blocking in 8% BSA in PBS for 1 hour at room temperature, cells
were incubated at 4uC overnight with the primary antibodies
diluted in 1% BSA. After washing for 5 minutes with PBS, cells
were incubated for 1 hour with fluorescein isothiocyanate (FITC)
or tetramethyl rhodamine isothiocyanate (TRITC)-conjugated
secondary antibodies. Rabbit anti-collectrin, mouse c-tubulin,
mouse anti-acetylated a-tubulin, mouse anti-Golgi 58K (Sigma),
mouse anti-disulfide isomerase (Stressgen, Bictoria, Canada),
rabbit anti-EGFR (Santa Cruz) were used. The cells were then
examined by a confocal laser scanning microscope, Laser Scan-
ning System LSM 510 (Carl Zeiss, Jena, Germany). Immuno-
electron microscopy was performed using rabbit anti-collectrin
antibody (1:300 dilution) and goat anti-rabbit IgG conjugated with
15 mm colloidal gold (Amersham) as secondary antibody (1:20
dilution)[16].
Quantification of primary cilium numbers and
length in mIMCD3 cells
Immunofluorescence images of primary cilia double stained with
collectrin and acetylated tubulin were generated using LSM510
confocal microscope system (Zeiss). Percentage of the cells with
visually detectable cilia was evaluated in ,200 mIMCD3 cells and
measurements of cilia length were determined using Zeiss LSM
image browser software.
Organ culture and antisense experiments
Embryonic kidneys were harvested from pregnant Crl:CD-1 (ICR)
mice at day 13 of gestation (E13)[17]. Antisense-phosphoro-
thioated oligodeoxynucleotides (ODNs) of collectrin, HNF1a,
HNF1b and a nonsense ODN were prepared as follows; 59-
CTCTGAAGAGGTATTCTTGATCCGT-39,5 9-TCAGGTC-
CCCTCGACTCCACCGCA-39 and 59-ATAGTCGTCGCCG-
TCCTCTGAGCCCTC-39, and 59-TAATGATATAATGATT-
GTAATGATAGTAGT-39. E13 metanephroi were maintained in
an organ culture containing 12.5 mg/ml of epidermal growth
factor (EGF). The antisense and nonsense ODNs were added to
the culture medium daily at concentrations ranging from 1.5 to
2.5 mM for 4 days, and the metanephroi were subjected to
quantitative real-time PCR. PCR was optimized and carried out
on an ABI PRISM 7000 sequence detection system (Applied
Biosystems) using ABsolute
TM QPCR SYBR Green Mix (ABgene,
Rochester, NY). For each gene, the denaturation at 95uC for
15min was followed by 40 cycles of denaturation at 95uC for
15 sec, annealing at 60uC for 30 sec and extension at 72uC for
30 sec. Gene specific primers for collectrin (Genbank accession
#AF178085), Pkhd1 (NM_153179), Pkd2 (NM_008861), Umod
(NM_009470), Tg737/Polaris (NM_009376) and b-actin
(NM_007393) were as follows: collectrin forward (59-GCAATTG-
CACTACTGGTTCTAT CTG-39), collectrin reverse (59-TCCA-
CTCCAGGTGGTCCTTT-39), Pkhd1 forward (59-TG ACCTT-
TTCTAGAT TGGCTGTCTT-39), Pkhd1 reverse (59-GT
HNF-1b-Targeted Collectrin
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TGAGCGTGAGCATCAACAGAT-39), Pkd2 reverse (59-T
GGTAAAGAGCTGT GTTCCAAGTC-39), Umod forward (59-
AGGTGTCCAGGCCTCAGTG T-39), Umod reverse (59-
GGAAACAACAGCAGCCAGATG-39), Tg737/Polaris forward
(59-TGCCT GGGACAGATGAA CCT-39), Tg737/Polaris reverse
(59-AGGGCCCAGTGGATCCA-39), b-actin forward (59-
GGCGCT TTTGACTCAGGATT-39), b-actin reverse (59-
GGGATGTTTGCTCC AACCAA-39).
Data analysis
Data were expressed as mean6s.e.m. Multiple groups were
compared by analysis of variance (ANOVA). Two-group analysis
was performed by t-test.
RESULTS
Collectrin is transcriptionally regulated by HNF-1b in
collecting duct cells
To investigate the transcriptional regulation of collectrin gene,
,500-bp of the 59 flanking promoter region of rat collectrin gene
was cloned. Transcriptional elements and consensus sequence of
HNF-1 binding site were identified[13]. Comparison of the rat,
human and mouse collectrin genes using GenBank data revealed
that HNF-1 binding site was conserved. RT-PCR and Western
blot analyses revealed that HNF-1b was expressed in mIMCD3
cells, while HNF-1a was not detected. HNF-1a mRNA and
protein were detected in mIMCD-3 cells transfected with
pcDNA3.1/HNF-1a (Figure 1a). The binding of HNF-1 to the
putative promoter elements in mIMCD3 cells was confirmed by
electrophoretic mobility shift assay (EMSA) (Figure 1a). The
incubation of DNA probes of putative HNF-1 binding site with
nuclear extracts from non-transfected or pcDNA3.1/HNF-1a
transfected mIMCD3 cells revealed specific DNA-protein complex
formation. The collectrin gene promoter was inserted into
promoterless pGL3-Basic vector, where the transcription of the
luciferase gene was driven by the collectrin promoter. This
construct was cotransfected into mIMCD3 cells with pcDNA3.1/
HNF-1a and/or pcDNA3.1/HNF-1b vectors. As shown in
Figure 1b, cotransfection with pcDNA3.1/HNF-1a and/or
pcDNA3.1/HNF-1b vectors accentuated luciferase activity in
a dose dependent manner. These results indicated that HNF-1a
and HNF-1b regulate the transcription of collectrin gene via HNF-
1 binding consensus sequence present in its promoter.
Dominant negative mutations of HNF-1b inhibited
collectrin expression in vivo
HNF-1b is expressed in renal collecting duct cells both in tissues
and cell lines. Whole kidney membrane fractions from dominant-
negative HNF-1b mutant (DN-HNF1b) transgenic mice[11] were
extracted to confirm transcriptional regulation of collectrin by
HNF-1b. DN-HNF1b transgenic founders with lower expression
of transgene had smaller decrease in collectrin, and the transgenic
founder with higher transgene expression exhibited remarkable
decrease in collectrin revealed by Western blot analysis using
whole kidney lysates (Figure 1c). Next, we examined the
expression of collectrin in collecting ducts in HNF-1b deletion
mutant lacking C-terminal domain tagged with V5 epitope
(HNF1bDC) transgenic mice[12]. The kidney tissue sections from
transgenic founders, chimeric mice with wild type HNF-1b and
HNF-1b deletion mutant, were stained with collectrin antibody
(red) and V5 antibody (green) (Figure 1d) and nuclei were
counterstained blue with 49-6-diamidino-2-phenylindole. The
luminal expression of collectrin was absent on the epithelial cells
(arrows) in which HNF1bDC was highly expressed in the nuclei
(green); while collectrin was apparently expressed in surrounding
normal collecting duct cells that did not express HNF1bDC
transgene product (blue).
Collectrin localizes to primary cilia
Plasma and vesicle membrane fractions from mouse and rat renal
medulla were associated with aquapirin-2 and snapin, respectively
(Figure 2a). The molecular weight of collectrin, ,40 kDa, was
similar in mouse, rat and human, both in plasma and vesicle
membrane fractions. Collectrin is a glycosylated protein since the
predicted molecular weight from amino acid sequence was
,26 kDa. Deglycosylation with N- and O-glycosidase resulted in
the reduction in molecular weight, i.e. 30 kDa and 35 kDa,
respectively (Fig. 2b). Next, subcellular localization of collectrin
by immunofluorescence was investigated. Focal planes of single
mIMCD3 cell were obtained; the nuclear focal plane indicated
that collectrin localized in cytoplasm, and the apical focal plane
revealed the presence of collectrin on apical plasma membrane
(Figure 2c).
Scanning the mIMCD3 cells using confocal microscopy from
basal cell attachment to apical top and re-construction of three-
dimensional images indicated that primary cilia displayed intense
immunoreactivities. Double staining of anti-acetylated a-tubulin,
marker for primary cilia, and anti-collectrin antibodies confirmed
that collectrin expression was concentrated in primary cilia
(Figure 2d). Higher magnification of the apical focal plane
clearly showed the co-localization of collectrin and acetylated a-
tubulin on primary cilium (Figure 2e). Collectrin immunoreac-
tivities (green) were seen surrounding the ciliary basal body, the
latter is visualized with anti-c-tubulin antibody (red)(Figure 2f).
Similarly, immunoelectron microscopy revealed that gold particles
were associated with the vesicles adjacent to the basal bodies, while
they were not integrated into the basal body microtubule
structures. Gold particles were also located at ciliary membranes
surrounding the microtubules, whereas few gold particles were
observed at the peripheral region of the centriole (Figure 2g).
Cilia formation is disrupted by collectrin siRNA
treatment
To demonstrate the role of collectrin in cilia formation, stable
mIMCD3 cell lines over-expressing collectrin (collectrin stable)
were generated. All 4 cell lines revealed ,3-fold over-expression
compared with control pcDNA3.1 stably transfected mIMCD3
cells (mIMCD3 cells) (Figure 3a). The siRNA treatment
significantly suppressed collectrin expression in mIMCD3 cells,
while the control siRNA had no effect (Figure 3b). Confocol
microscopy also revealed that collectrin was over-expressed in
collectrin stable cells and knocked down by siRNA revealed by
confocol microscopy (Figure 3c). The fully polarized mIMCD3
cells were associated with single primary cilia, and the cilia
formation was not disturbed in control siRNA treated cells or
collectrin stable cell lines (Figure 3d). However, primary cilia
were absent in ,40% of the cells treated with collectrin siRNA
(Figures 3d and 3e). In addition, morphometric analyses of the
existing primary cilia indicated that mIMCD3 cells transfected
with siRNA had shorter or stunted primary cilia compared with
those of control siRNA treated cells (Figures 3d and 3f). By
electron microscopy (Figure 3g), the treatment of siRNA resulted
in various abnormalities of primary cilia, e.g. disorganization of
9+0 microtubular structure of basal bodies (arrow head), bulging
basal bodies (arrow), and stunted shaft projection (asterisk).
HNF-1b-Targeted Collectrin
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effects of collectrin siRNA
Since polycyctin-2 reveals ciliary localization and the intracellular
trafficking of polycystin-2 is regulated both at the level of the
endoplasmic reticulum and the trans-Golgi network, subcellular
expression of collectrin and polycystin-2 in mIMCD3 cells was
assessed. Inhibition of collectrin expression by siRNA showed
negative impact on polycystin-2 protein expression in mIMCD3
cells (Figure 4a). Double staining showed that collectrin was fully
co-localized with Golgi marker and also partially localized in
endoplasmic reticulum (ER) (Figure 4b). As expected, collectrin
and polycystin-2 colocalized in the cytoplasm of mIMCD3 cells
(Figure 4c). Apical view by confocal microscopy indicated that
polycystin-2 was highly expressed on primary cilia and in the
cytoplasm of mIMCD3 cells, whereas polycystin-2 disappeared
both in the cilia and cytoplasm of most of the cells transfected with
collectrin siRNA (Figure 4d).
Figure 1. Transcriptional regulation of collectrin gene by HNF-1b. Panel a: Western blot analysis, RT-PCR and electrophoretic mobility shift assay
(EMSA). Endogenous mRNA expression of HNF-1b but not HNF-1a in mIMCD3 cells is detected by Western blot analysis and RT-PCR. The specific
binding of HNF-1b and HNF-1a to putative binding site is indicated by antibody mediated supershift (arrow). Panel b: Luciferase reporter gene assay.
The mIMCD3 cells are co-transfected with pcDNA3.1/HNF-1a and/or pcDNA3.1/HNF-1b with pGL3-collectrin reporter and pBIND vector. A dose
dependent increase in the reporter activity is observed (n=6, *p,0.05 and **p,0.01 versus pcDNA3.1(+) treated control) Panel c: Western blot
analyses of collectrin using whole kidney lysates of DN-HNF1b transgenic mouse. In two transgenic mouse founders, the expression of DN-HNF1b
mutant transgene tagged with V5 and FLAG epitope is indicated by percentage of highest expression, 6% and 100%. (Western blot analysis using
anti-FLAG antibody, n=3 separate measurements, *p,0.05 and **p,0.01 versus non-transgenic littermate indicated by 0%) Panel d: Localization of
collectrin and HNF-1b deletion mutant protein in epithelia lining the cyst shown by immunofluorescence microscopy. Collectrin is visualized as red,
HNF-1b deletion mutant with V5 tag as green, and nuclei as blue. Arrows indicate the absence of collectrin expression on the apical surface of
epithelial cells where HNF-1b deletion mutant product is expressed in the nucleus. Scale bar, 20 mm.
doi:10.1371/journal.pone.0000414.g001
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PLoS ONE | www.plosone.org 5 May 2007 | Issue 5 | e414Figure 2. Subcellular localization of collectrin in kidney tissues and mIMCD3 cells. Panel a: Western blot analyses of snapin, aquaporin-2 and
collectrin, isolated from plasma membrane (PM) and vesicle membrane (VM) fractions. Collectrin antibody detected a single band of ,40 kDa. Panel
b: N-glycosidase (N) and O-glycosidase (O) treatment generates ,30 kDa and ,35 kDa respective bands. Panel c: Immunoreactivity of collectrin is
detected by confocal microscopy; five layers (1 to 5) are shown and collectrin is seen in cytoplasm (2 to 5 cuts) and apical membrane (1 cut). Panel d:
Apical view of mIMCD3 cells. Collectrin (green) and acetylated a-tubulin (red), a primary ciliary marker, are depicted. Panel e: Higher magnification
shows that acetylated a-tubulin (red) and collectrin (green) co-localize. Panel f: Collectrin (green) is seen surrounding the c-tubulin, a marker for the
basal body (red). Panel g: Immunoelectron microscopy shows gold particles localized mainly in microvesicles around the basal body of the primary
cilium (arrow heads), whereas few gold particles are observed at the peripheral region of proximal centriole. Scale bars, 20 mm for panels c, d, e, and f
and 500 nm for panel g.
doi:10.1371/journal.pone.0000414.g002
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PLoS ONE | www.plosone.org 6 May 2007 | Issue 5 | e414Figure 3. Primary cilium formation in mIMCD3 cells. Panel a: Expression of collectrin in mIMCD3 cells over-expressing collectrin (n=4; clone 11, 13,
15 and 18) and mIMCD3 cells stably transfected with pcDNA3.1(+) (n=2; clone c1 and c2)(mIMCD3 cells). (*p,0.05 versus mIMCD3 cells) Panel b:
Western blot analysis of collectrin in mIMCD3 cells treated with control siRNA (CON-siRNA) or Collectrin siRNA. (Data represent 3 independent
experiments, *p,0.01 versus CON-siRNA) Panel c: Immunofluorescence of collectrin in mIMCD3 cells, CON-siRNA and Collecrin siRNA treated cells,
and Collectrin stable cells. Panels d & e: mIMCD3 cells double-stained with collectrin (green) and acetylated a-tubulin (red). Cilia are present in every
polarized cell, but ,40% of cells are without detectable cilia with the treatment of collectrin siRNA. AV, apical view. (n=300 from separate three
experiments, *p,0.05 versus CON-siRNA) Panel f: Cilium length is also reduced in cells after collectrin siRNA transfection (,4.5 mm) compared with
CON-siRNA group (,7.8 mm). (n=300 from three independent experiments, *p,0.05 versus CON-siRNA) Panel g: Electron micrographs of mIMCD3
cells treated with CON-siRNA and Collectrin siRNA. Cilium with disorganized microtubule structure (arrow heads), bulging cilium (arrows), and stunted
cilium (asterisk) are seen in mIMCD3 cells transfected with Collectrin siRNA. Scale bars, 20 mm for panels c and d and 500 nm for panel g.
doi:10.1371/journal.pone.0000414.g003
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PLoS ONE | www.plosone.org 7 May 2007 | Issue 5 | e414Figure 4. Expression and localization of polycystin-2 in mIMCD3 cells treated with collectrin siRNA. Panel a: Western blot analyses show down
regulation of polycystin-2 in mIMCD3 cells transfected with collectrin siRNA (Collectrin siRNA). Collectrin expression is not altered in mIMCD3 cells
treated with control siRNA (CON-siRNA) and mIMCD3 cells over-expressing collectrin (Collectrin stable). (Data represent 3 independent experiments,
*p,0.05 versus CON-siRNA) Panel b: mIMCD3 cells double-stained with anti-collectrin antibody and organella markers. Golgi 58K protein (58K-9)
(red) and collectrin (green) are co-localized in cytoplasm of mIMCD3 cells. Endoplasmic reticulum (ER) marker, protein disulfide isomerase (red), and
collectrin (green) show partial colocalization. Panel c: mIMCD3 cells double-stained with polycystin-2 (green) and collectrin (red) showing co-
localization. Panel d: mIMCD3 cells double-stained with polycystin-2 and acetylated a-tubulin. Polycystin-2 is highly expressed in primary cilia and the
apical membrane of mIMCD3 cells, CON-siRNA treated and Collectrin stably transfected cells, whereas polycystin-2 is not detected in the cilia of most
of the cells transfected with collectrin siRNA. AV, apical view. Scale bars, 10 mm for panels b, c, and d.
doi:10.1371/journal.pone.0000414.g004
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vesicle transport and fusion
Further insight into the role of collectrin was investigated by
examining protein:protein interactions with ciliary proteins, such
as polycyctin-2 and polaris[18]. Co-precipitation of collectrin and
polycystin-2 or collectrin and polaris (Figure 5a) indicated it
forms a complex with polycystin-2 and polaris. Next, collectrin-
interacting molecules were identified by yeast two-hybrid system.
After screening more than 10
7 independent clones using in-
tracellular domain of collectrin as bait, snapin, SNAP-25
(synaptosomal-associated protein of 25 kDa) binding protein, was
isolated. In a previous study, snapin was also isolated by the yeast
two-hybrid system using full-length of collectrin as bait[13].
Snapin is a component of SNARE (soluble N-ethylmaleiamide-
sensitive factor attachment protein receptor) and immunoprecip-
itation study showed collectrin co-precipitated with snapin. In
mIMCD3 cells, collectrin also co-precipitated with SNARE
proteins, SNAP-23 and syntaxin-4, suggesting collectrin binds to
SNARE complex by interacting with snapin (Fig. 5b). Further
screen of the protein complexes using tandem affinity tag
purification and mass spectrometry was performed. Collectrin
cDNA lacking N-terminal signal sequence was cloned into pNTAP
and transiently transfected into mIMCD3 cells. Purified proteins
were analyzed with SDS-PAGE that revealed two major bands.
MALDI-TOF MS identified them as nonmuscle myosin heavy
chain II-A (myosin heavy polypeptide 9) and c-actin. Co-
immunoprecipitation study revealed collectrin forms the protein
complex with c-actin, myosin II-A, tropomyosin, and polycystin-2
(Figure 5c). Although collectrin knockdown alter the intensity
and pattern of acetylated a-tubulin, collectrin siRNA treatment
did not alter the expression and staining pattern of c-actin, myosin
II-A, and tropomyosin revealed by Western blot analysis and
immunofluorescence study (data not shown).
Collectrin regulates cell proliferation, apoptosis, and
polarity
PCNA immunostaining and 5-bromo-29-deoxyuridine (BrdU)
assays showed an increased proliferation activity in mIMCD3
cells transfected with collectrin siRNA, while the stable over-
expression of collectrin had no notable effect on cell proliferation
(Figures 6a, 6b and 6c). To examine the effects of collectrin on
apoptosis, TUNEL assay was performed in mIMCD3 cells. The
number of apoptotic cells notably increased in mIMCD3 cells
transfected by collectrin siRNAs compared with negative control
siRNA treated cells. Over-expression of collectrin did not show
any alterations in percentage of apoptotic cells (Figures 6d and
6e). Although collectrin siRNA-treated mIMCD3 cells underwent
apoptosis and revealed proliferation activity, overall viable cell
numbers were not altered shown by MTT assay (Figure 6e).
Since up-regulation and mis-polarization of epidermal growth
factor receptor (EGFR) is linked to abnormal cell proliferation, the
expression of EGFR was investigated. EGFR was normally
expressed on lateral membrane in mIMCD3 cells, and transient
transfection with control siRNA or stable trasfection of collectrin
gene did not alter the distribution. Besides lateral membrane
expression, the EGFR was also seen mis-localized on the apical
membrane in the cells treated with collectrin siRNA, a character-
istic feature observed in tubular epithelia lining the cysts in human
and animal polycystic kidneys[18,19] (Figure 6g). The Western
blot analysis revealed that over-expression of collectrin is
associated with reduced EGFR, in turn, the repression of collectrin
resulted in up-regulated EGFR expression (Figure 6h).
Collectrin antisense ODN treatment of metanephric
organ culture
Addition of EGF (12.5 mg/ml) and nonsense ODN resulted in
hypertrophy of the fetal kidney without apparent cyst formation
(Figure 7a-B) compared with nonsense ODN treated control
explants (Figure 7a-A). Inclusion of collectrin antisense ODN was
associated with formation of cleft-like structure (arrows) in the
ureteric bud branches in a dose-dependent manner (Figures 7a-C
and -D). Addition of HNF-1a antisense ODN into the metanephric
organ culture media also resulted in the formation of multiple cleft-
like cysts (Figures 7a-E-F), while the number or size of the cyst
formation were relatively more in the metanephroi with the
treatment of HNF1-b antisense ODN (Figures 7a-G and H).
The mRNA expression of collectrin and the genes under the control
ofHNF-1aandHNF-1bwasinvestigated.CollectrinantisenseODN
suppressed collectrin gene expression along with that of HNF-1,
regulator of Pkd2and Umod. Notably, the expression of collectrin was
inhibited by HNF-1b antisense ODN, however, inhibitory effect was
not seen inHNF-1a antisenseODN treated group(Figure 7b).The
addition of HNF-1b antisense ODN resulted in global inhibitory
effects on HNF-1 regulated genes compared with HNF-1a antisense
ODN treated metanephroi except Tg737/Polaris.
Collectrin expression decreased in polycystic
kidneys
To investigate collectrin expression and localization in cystic
kidneys, we performed immunochemistry on the kidneys from
HNF1bDC transgenic mice. Transgenic mice at postnatal day-52
(P52) and P100 were compared with a non-transgenic littermate at
P52. The kidney-specific expression of HNF1bDC was associated
with renal cyst formation and extensive interstitial fibrosis
throughout the parenchyma of the kidney (Figure 8a). Collectrin
was expressed in cytoplasm and apical membrane throughout
Figure 5. Collectrin and interacting proteins. Panel a: Immunopre-
cipitation indicates interaction between collectrin and polycystin-2, and
between collectrin and polaris. Panel b: Collectrin co-precipitates with
snapin, SNAP-23, and syntaxin-4. Panel c: Tandem affinity tag
purification using collectin as a bait followed by SDS-PAGE and MALDI
TOF MS analysis revealed that the major two bands are nonmuscle
myosin heavy chain II-A and c-actin. Immunoprecipitation study shows
collectrin, myosin II-A, c-actin, tropomyosin, and polycystin-2 forms
protein complex.
doi:10.1371/journal.pone.0000414.g005
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PLoS ONE | www.plosone.org 9 May 2007 | Issue 5 | e414collecting duct cells in the non-transgenic mice. In HNF1bDC
transgenic mice, weak apical expression was detected in morpho-
logically normal collecting ducts, while the signals were barely
detectable in single-layered or mutilayered cysts (Figure 8b).
Collectrin in the kidney tissues from ADPKD patients was seen
localized in morphologically normal tubules, whereas the epithelial
cells lining single cell- and multi-layered cysts showed weak or
lacked collectrin expression (Figure 8c).
DISCUSSION
In the kidney, HNF-1b, a transcriptional factor, has been shown to
modulate activities of several target genes in tubular epithelia,
namely Umod, Pkhd1, Pkd2 and Tg737/Polaris. Mutations in these
genes have been described in various forms of cystic diseases.
Although HNF-1a and HNF-1b bind to the target site with similar
affinities, either as homo- or hetero-dimers, the findings of the
Figure 6. Proliferation, apoptosis, and mislocalization of epidermal growth factor receptor (EGFR) in mIMCD3 cells treated with collectrin siRNA.
Panels a & b: Cellular proliferation assessed by proliferating cell nuclear antigen (PCNA) staining. PCNA positive cells increase in mIMCD3 cells treated
with collectrin siRNA compared with control siRNA treated cells (CON-siRNA) and mIMCD3 cells over-expressing collectrin (Collectrin stable). Panel c:
The increased proliferation of cells is observed in collectrin siRNA group by BrdU assay. Panels d & e: Apoptosis assay using TdT-mediated dUTP nick
end labeling (TUNEL) method. Increased number of apoptotic cells is observed in collectrin siRNA group. Panel f: The viability of the cells is not
altered in all groups revealed by MTT assay. Panel g: Imunofluoresence and confocal micrographs of EGFR. EGFR is observed in basolateral
membrane of mIMCD3 cells, control siRNA group, and collectrin stable cells, whereas apical membrane expression of EGFR is detected in collectrin
siRNA group. Panel h: Western blot analyses of EGFR. EGFR is up-regulated in collectrin siRNA group and down-regulated in cells stably transfected
with collectrin. Scale bars, 20 mm for panel f. N=300 from separate three experiments for panels b, c and e. Data are from 3 independent experiments
for panel g, *p,0.05, **p,0.01 versus CON-siRNA.
doi:10.1371/journal.pone.0000414.g006
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PLoS ONE | www.plosone.org 10 May 2007 | Issue 5 | e414Figure 7. Collectrin antisense experiments in mouse metanephric organ culture system. Panels aA & aB: Addition of EGF (12.5 mg/ml) (EGF) into
culture media induces hypertrophy of the fetal kidney without cyst formation compared with nonsense ODN (oligodeoxynucleotide)-treated control
explants (CON). Panels aC & aD: The formation of cleft-like cysts (arrows) in the ureteric bud branches are seen in collectrin antisense ODN treated
groups at concentrations of 1.5 mM (COLL-1.5) and 2.5 mM (COLL-2.5). Panels aG & aH: The formation of multiple cleft-like cysts is accentuated in
metanephroi treated with HNF-b antisense ODN at concentrations of 1.5 mM (HNF-b-1.5) and 2.5 mM (HNF-b-2.5). Panels aE & aF: Similar effect,
although somewhat less, is seen in HNF-1a antisense ODN treated group at concentrations of 1.5 mM (HNF-a-1.5) and 2.5 mM (HNF-a-2.5). Panel b:
mRNA expression of collectrin and the genes regulated by HNF-1a and HNF-1b including Pkhd1, Pkd2, Umod, and Tg737/Polaris. Scale bars, 200 mm
for panel a.
doi:10.1371/journal.pone.0000414.g007
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PLoS ONE | www.plosone.org 11 May 2007 | Issue 5 | e414Figure 8. Collectrin expressions in polycystic kidneys. Panel a: Kidney tissues from nontransgenic littermates at postnatal day 52 (P52), HNF1bDC
transgenic mice at P52, and HNF1bDC transgenic mice at P100. Numerous renal cysts are formed in kidneys of HNF1bDC transgenic mice. (Masson-
Trichrome) Panel b: Immunoperoxidase staining of collectrin. Abundant expression of collectrin is seen in nontransgenic mice P52. Collectrin
immunoreactivity is readily seen in normal portion of collecting duct cells (arrow head) but not seen in the epithelia lining the cysts (arrow) in
HNF1bDC transgenic mice. Panel c: Collectrin immunoperoxidase staining in kidney tissues form normal human and ADPKD patients. Abundant
expression of collectrin is seen in normal collecting duct cells. In ADPKD patients, collectrin expression is observed in normal collecting duct cells
(arrow head); however immunoreactivity of collectrin is not seen in both single-layered (arrow) and multilayered cysts. Scale bars, 1 mm for panel a,
50 mm for panels b and c.
doi:10.1371/journal.pone.0000414.g008
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HNF-1b in the kidney. In the kidney tissues, HNF-1a was
expressed exclusively in the nuclei of renal proximal tubular cells,
while HNF-1b was expressed in all segments of the nephron,
including collecting ducts[7]. Interestingly, the RT-PCR analyses
revealed that both HNF-1b and collectrin are co-expressed in
collecting duct and respective cell lines, including mIMCD-3,
mIMCD-K2, RCCD1, RCCD2, and M-1 cells, suggesting
a potential functional association between these two molecules.
Besides kidney, collectrin is also co-expressed with HNF-1b in
pancreatic islets[13], suggesting that the transcriptional activities
are perhaps under tight and specific control of HNF-1b.
Many of HNF-1b driven proteins linked to PKD in mouse and
human localize to the primary cilium[20,21]. Cilia are rod-like
organelles originating from the basal body and related to the
centriole. Their basic structure consists of a central axoneme
composed of 9 doublets of microtubules and a ciliary membrane
that is continuous with plasmalemma. One to two primary cilia
are present on the surface of most vertebrate cells and also on the
apical surface of tubular epithelia of mammalian kidney[22]. A
series of discovery began from an insertional mutagenesis screen in
mice and the mutation in Tg737 gene was found to cause recessive
form of PKD in orpk mice[23]. The protein product of Tg737,
polaris, is localized in the axoneme and basal body. It seems to be
essential for ciliary assembly and intra-flagellar transport[24,25].
In addition to structural abnormalities of cilia, functional defects
were noted in Invs[26] and Cys1[27], and both mouse mutants
revealed ARPKD phenotype. Later studies revealed that the
PKD1 product, polycyctin-1, as well as polycystin-2, polaris, and
cystin are all found to be localized to primary cilia in cultured
mouse cortical collecting duct cells[28]. Interestingly, defects in
primary cilia are seen in Bardet-Biedl syndrome (BBS), charac-
terized by mental retardation, pigmentary retinopathy, poly-
dactyly, obesity, renal cyst formation and hypogenitalism. Among
8 causal genes, BBS8 protein localizes to centrosomes and basal
bodies and co-localizes with c-tubulin and BBS4[29,30]. Although
ciliary functions in renal tubules are incompletely understood, this
organelle most likely functions as a flow-sensitive mechanosensor
to luminal fluid flow, modulates flow-sensitive ion transport and
possibly regulates cell proliferation and differentiation[31].
Like other genes involved in cystogenesis, it is reasonable to
speculate that the HNF-1b-driven collectrin plays a role in ciliary
functions and thereby in cystogenesis in PKD, since collectrin co-
localized with acetylated a-tubulin, maker for primary cilium. In
peri-basal body region of primary cilium, collectrin was seen
surrounding basal body marker, c-tubulin, and it revealed
Figure 9. Models for the trafficking of cilliary integral membrane proteins.
doi:10.1371/journal.pone.0000414.g009
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microscopy (Figures 2 and 9). Cilia and flagella are unable to
synthesize the various ciliary proteins, and thus all non-membrane-
bound proteins needed for elongation of the primary cilium are
transported to the ciliary tip to endow it with functional
properties[32,33]. The process is accomplished by a transport
apparatus known as the intraciliary or intraflagellar transport (ICT
orIFT) system.In Chalamydomonas, the IFT particles are composed of
at least 17 subunits; the IFT polypeptides move in antrograde
direction to the flagellar tip by kinesin-II and move in the retrograde
direction to the base of the flagellum by cytoplasmic dynein 1b[34].
However, it is not clear how integral membrane proteins are
transported within cilia and flagella. Since some membrane proteins
are concentrated in the ciliary membranes, the barrier has to exist at
the base of cilium to prevent backward diffusion out of the cilium or
one-way barrier facilitates the transportation of integral proteins
from the apical plasma membranes[35] (Fig. 8); the former is rather
conceivable and the base of the cilium would be expected to serve as
an initial docking station[36].
Snapin is a 15 kDa protein containing predicted coiled-coil
domain in its C-terminal half[37] and it has been reported to bind
to synaptic SNARE (soluble N-ethylmaleimide-sensitive-factor
attachment protein receptor) complex via a direct interaction
with SNAP-25 and SNAP-23 and thus is believed to be involved in
vesicle fusion and trafficking[38]. Our previous studies suggest
a direct binding between collectrin and snapin by yeast two hybrid
system and GST-pull-down assay[13]. Furthermore, immunopre-
cipitation studies in pancreatic b cell line, INS-1 cell, indicated
that collectrin binds to SNARE complex, consisting vesicle-
associated membrane protein-2 (VAMP-2), syntaxin-1 and SNAP-
25, via direct interaction with snapin[13]. Incidentally, the
presence of SNARE proteins such as SNAP-23, syntaxin-4 and
VAMP-2 has been reported in collecting duct cells[39]. The
current studies extended the observations and demonstrated that
collectrin co-immunoprecipitated with snapin and SNARE
proteins, SNAP23 and syntaxin-4 in collecting duct cells. In
addition, complex formation of collectrin with c-actin, myosin II-A
(non-muscle heavy chain II-A), and tropomyosin was elucidated.
The interaction of actin with non-muscle myosin II-A assembled
around aggregates of secretory vesicles facilitate their exocytosis in
lacrimal acinar epithelial cells[40]. In other cell types, myosin II is
involved in vesicle budding from Golgi[41], intracellular vesicle
movement or trafficking[42–45], and membrane docking[40,46].
Inview of these processesdescribedinothercelltypesand elucidated
in this investigation, it would suggest that collectrin in association
with SNARE and actin-myosin complex mediates specific vesicle
transport and docking to drive the integral membrane proteins to
ciliary membranes. In support of such a contention, the application
of collectrin siRNA to mIMCD3 cells resulted in severe defects in
cilium formation and subsequent loss of polycystin-2 on cilia,
increased cell proliferation and apoptosis, and overexpression of
EGFR and its mislocalization. This phenomenon is consistent with
the facts that the presence of a cilium is associated with the
establishment of polarity and differentiation of the cells in the
stationary or G0 phase of the cell cycle. In many cells, the entry into
the cellcycle ispreceded byciliaryresorption;whileexit frommitosis
is accompanied by cilium formation[47].
Another significant finding of our study is that collectrin forms
complex with polycystin-2 and Tg737/Polaris. Polycystin-1 is a G
protein-coupled transmembrane receptor that acts as a ciliary
mechanosensor and regulates calcium channel activities of
polycystin-2. Polycystin-1 and -2 forms a hetrerodimer complex
in primary cilium and polycyctin-2 responds to signals from
polycystin-1 induced by the ciliary flexing to generate influx of
calcium[31]. Polycystin-1 and polycystin-2 was co-localized both
in apical and basolateral membranes including primary cilium,
cell-cell adherens junction, and cell-matrix focal adhesion. In
contrast to polycystin-1, the presence of polycystin-2 in endoplas-
mic reticulum (ER) and Golgi apparatus suggests that ER and
Golgi are recycling pool or the site of polycystin-2 activity[48].
The trafficking of proteins to specific subcellular compartments is
governed by multiple protein-protein interaction following post-
translational modifications[49]. Polycystion-2 is phosphorylated
on Ser812 by protein kinase (CK2), binds to phosphofurin acidic
cluster sorting protein/Golgi-derived coat protomer I (PACS2/
COPI), and is retrieved on the ER. Dephosphorylation of
polycystin-2 by protein phosphatase 2A (PP2A) facilitates poly-
cystin-2 translocation to the plasma membrane by releasing from
the interaction with PACS proteins[50]. Similarly, the retrieval to
the Golgi is mediated by PACS-1/adaptin. Other molecules that
may modulate these events include CD2-associated protein
(CD2AP) which participates in endocytosis of polycystin-2, while
PIGEA-14 is involved in forward trafficking from the ER to the
Golgi[51]. The above literature information can be interfaced with
the current findings suggesting collectrin in association with
polycystin(s) modulate the ciliary pathobiology. The application of
collectrin siRNA into mIMCD3 cells reduced polycystin-2
expression and resulted in selective loss of polycystin-2 from
primary cilium, apical membrane and cytoplasm. The collectrin
expression in the Golgi apparatus and ER suggests that it may also
be involved in the ER-Golgi-plasma membrane trafficking of
polycyctin-2. Defective trafficking of the latter may be case in mice
with Tg737
orpk mutation where polycystin-2 is seen accumulated in
the stunted cilium, since Tg737/Polaris is not required for moving
polycystin-2 into cilia but is needed to recycle it to the cell
body[52]. The findings of the present investigation indicating an
association of collectrin and Tg737/Polaris may also suggest
a possible role of collectrin in such intraciliary recycling events
of integral transmembrane proteins.
In summary, it seems that collectrin is necessary for the
maintenance of primary cilium to supply the primary cilia-specific
integral membrane proteins, including polycystin-2, and it is
involved in multiple membrane trafficking processes; vesicle
transport, docking to base of primary cilia, ER-Golgi trafficking,
and intraciliary recycling. Credence to this notion comes from the
studies where suppression of collectrin expression resulted in
severe defects in cilium formation in mIMCD3 cells and slit like
cyst formation in mouse metanephric organ culture system.
Furthermore, the reduction of collectrin expression in cystic
tubular epithelia in HNF1bDC transgenic mice as well as in
human ADPKD patients would be supportive of the role of
collectrin in cystogenesis. Lack of phenotype of cyst formation in
collectrin knockout mice suggested that ACE2 may compensate of
collectrin action. The findings of this study that collectrin plays
a central role in pathways common to cystogenesis of various
hereditary cystic diseases should yield an impetus to develop new
therapeutic intervention for the treatment of PKD with collectrin
being a novel target.
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